查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1449396

痔疮治疗市场、占有率、市场规模、趋势、行业分析报告：按药物类型、按治疗类型、按应用、按最终用途、按地区、按细分市场、预测，2024-2032 年

Anal Fistula Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Anticholinergic, Proton-Pump Inhibitors, H2 Blockers, Antidiarrheals); By Treatment Type; By Application, By End Use, By Region, & Segment Forecasts, 2024-2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，预计到2032年，全球肛门瘘治疗市场规模将达到413.4亿美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

由于全球肛瘘盛行率上升，肛瘘治疗市场正在经历成长。 发炎性肠道疾病是导致胃肠道（GI）持续慢性发炎且没有可识别触发因素的主要原因。 肠造口治疗领域的收入成长取决于预测期内产品开发的进步、药物批准以及对生物製剂和生物相似药的日益偏好等因素。

单细胞 RNA 定序等技术进步正在帮助医疗保健专业人员管理肛瘘治疗。 单细胞RNA定序和质谱流式细胞仪等高维度技术已应用于从诊断为克隆氏症和溃疡性结肠炎的患者身上取得的肠道标本。 单细胞 RNA 定序分析的使用为瞭解疾病的分子基础提供了多种好处，包括探索创新的治疗策略、客製化个别药物和预防疾病。

多种因素导致肛瘘治疗市场的盛行率不断上升，包括遗传倾向、环境触发因素以及通常与克隆氏症相关的免疫系统失调。 被诊断患有溃疡性结肠炎或克隆氏症的患者中有很大一部分有家族史。 例如，霍普金斯医学院的一项研究发现，大约 10% 至 15% 的克罗恩病患者的亲属患有克罗恩病。 同样，大约 5% 至 7% 被诊断出患有溃疡性结肠炎的患者有家族史。

业界领导者为降低医疗成本而实施的报销策略预计将推动患者对有效治疗方案的良好认知。 增加对肠造口治疗的投资也能带来显着的投资回报 (ROI)，特别是当医生通常开立这些药物来治疗中度至重度肠造口疾病时。据预测， 此外，抗黏连分子，特别是整合素拮抗剂的开发，代表了解决肛门瘘的一个有前途的途径。 这些分子标靶参与沾黏形成的分子机制，有可能减少瘘管復发并改善患者预后。

肛瘘治疗市场报告亮点

2023 年，在干预措施的推动下，外科手术占了最大的市场占有率，尤其是瘘管手术，它成为治疗肛门瘘的患者的推荐和首选方法。

由于医院部门拥有先进的医疗基础设施（包括手术室和诊断能力），因此医院部门预计在预测期内的复合年增长率将是最快的。

北美由于其先进的医疗基础设施、设备齐全的医院、诊所和专业医疗设施，在 2023 年占最大的市场占有率。 获得最先进的诊断和治疗资源有助于有效和全面的肛瘘管理。

由于存在大量患有肠道疾病的人口，预计亚太地区在预测期内复合年增长率最快。

目录

第1章简介

第 2 章执行摘要

第3章研究方法

第4章全球肛瘘治疗市场洞察

  • 肛门瘘治疗 - 产业快照
  • 肛瘘治疗市场动态
    • 推动者和机会
      • 肠道疾病的发生率增加
      • 处理技术的进步
    • 抑制因素和挑战
      • 治疗费用高
  • 杵分析
  • 肛瘘治疗产业的趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第5章全球肛门瘘治疗市场（依药物类型）

  • 主要发现
  • 简介
  • 抗胆碱能作用
  • 质子帮浦抑制剂
  • H2 阻断剂
  • 止泻

第6章全球肛门瘘治疗市场，依应用划分

  • 主要发现
  • 简介
  • 括约肌间瘘管
  • 经括约肌瘘
  • 括约肌上瘘管
  • 其他

第7章全球肛门瘘治疗市场，依最终用途划分

  • 主要发现
  • 简介
  • 医院
  • 门诊手术中心
  • 其他

第 8 章全球肛瘘治疗市场（依治疗类型）

  • 主要发现
  • 简介
  • 手术
  • 非手术

第 9 章全球肛门瘘治疗市场（按地区）

  • 主要发现
  • 简介
    • 2019-2032 年肛门瘘治疗市场评估（按地区）
  • 肛门瘘治疗市场 - 北美
    • 北美：肛瘘治疗市场，依药物类型，2019-2032 年
    • 北美：2019-2032 年肛瘘治疗市场（依治疗类型）
    • 北美：2019-2032 年肛门瘘治疗市场（依应用）
    • 北美：肛瘘治疗市场，依最终用途，2019-2032 年
    • 肛门瘘治疗市场—美国
    • 肛瘘治疗市场 - 加拿大
  • 肛门瘘治疗市场 - 欧洲
    • 欧洲：2019-2032 年肛门瘘治疗市场（依药物类型）
    • 欧洲：2019-2032 年肛瘘治疗市场（依治疗类型）
    • 欧洲：肛瘘治疗市场，依应用划分，2019-2032 年
    • 欧洲：肛瘘治疗市场（依最终用途），2019-2032 年
    • 肛门瘘治疗市场 - 英国
    • 肛门瘘治疗市场 - 法国
    • 肛门瘘治疗市场 - 德国
    • 肛门瘘治疗市场 - 义大利
    • 肛瘘治疗市场 - 西班牙
    • 肛门瘘治疗市场 - 荷兰
    • 肛门瘘治疗市场 - 俄罗斯
  • 肛瘘治疗市场 - 亚太地区
    • 亚太地区：肛门瘘治疗市场（依药物类型），2019-2032 年
    • 亚太地区：肛门瘘治疗市场（依治疗类型），2019-2032 年
    • 亚太地区：肛门瘘治疗市场，依应用划分，2019-2032 年
    • 亚太地区：肛门瘘治疗市场（依最终用途），2019-2032 年
    • 肛门瘘治疗市场 - 中国
    • 肛瘘治疗市场 - 印度
    • 肛瘘治疗市场—日本
    • 肛门瘘治疗市场 - 马来西亚
    • 肛门瘘治疗市场—印度尼西亚
    • 肛瘘治疗市场－韩国
  • 痔疮治疗市场 - 中东和非洲
    • 中东与非洲：肛门瘘治疗市场（依药物类型），2019-2032 年
    • 中东与非洲：2019-2032 年肛瘘治疗市场（依治疗类型）
    • 中东与非洲：肛门瘘治疗市场，依应用划分，2019-2032 年
    • 中东和非洲：肛门瘘治疗市场（以最终用途），2019-2032 年
    • 肛瘘治疗市场－沙乌地阿拉伯
    • 肛门瘘治疗市场 - 南非
    • 肛门瘘治疗市场 - 以色列
    • 肛门瘘治疗市场 - 阿拉伯联合大公国
  • 肛门瘘治疗市场 - 拉丁美洲
    • 拉丁美洲：肛瘘治疗市场，依药物类型，2019-2032 年
    • 拉丁美洲：2019-2032 年肛瘘治疗市场（依治疗类型）
    • 拉丁美洲：肛瘘治疗市场，按应用划分，2019-2032 年
    • 拉丁美洲：肛瘘治疗市场，依最终用途，2019-2032 年
    • 肛门瘘治疗市场 - 墨西哥
    • 肛门瘘治疗市场 - 巴西
    • 肛瘘治疗市场—阿根廷

第10章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第11章公司简介

  • Angiplast Pvt. Ltd.
  • Avante Health Solutions
  • Biolitec AG
  • Cliniva Healthcare
  • Cook Medical
  • Gulmaher Surgico
  • Integra LifeSciences
  • KARL STORZ
  • Medtronic plc
  • Novo Surgical Inc.
  • Signum Surgical
  • Sklar Surgical Instruments
Product Code: PM4582

The global anal fistula treatment market size is expected to reach USD 41.34 billion by 2032, according to a new study by Polaris Market Research. The report "Anal Fistula Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Anticholinergic, Proton-Pump Inhibitors, H2 Blockers, Antidiarrheals); By Treatment Type; By Application, By End Use, By Region, And Segment Forecasts, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The anal fistula treatment market is experiencing growth propelled by the global increase in the prevalence of this condition. Inflammatory bowel diseases are a primary cause, leading to persistent chronic inflammation of the gastrointestinal (GI) tract without identifiable triggers. Revenue expansion in the intestinal fistula treatment sector is anticipated due to factors like advancements in product development, drug approvals, and a growing preference for biologic and biosimilar medications throughout the forecast period.

Advancements in technology, exemplified by single-cell RNA sequencing, are aiding healthcare practitioners in managing anal fistula treatment. High-dimensional techniques like single-cell RNA sequencing and mass cytometry have been applied to intestinal specimens obtained from individuals diagnosed with Crohn's disease or ulcerative colitis. The utilization of single-cell RNA sequencing analysis offers various advantages in comprehending the molecular underpinnings of the disease, including the exploration of innovative therapeutic strategies, customization of individual medications, and disease prevention.

Multiple factors contribute to the escalating prevalence of the anal fistula treatment market, including genetic predisposition, environmental triggers, and immune system dysregulation, often associated with the Crohn's Disease. A significant proportion of patients diagnosed with ulcerative colitis or Crohn's disease exhibit a familial history of the condition. For instance, research conducted by Hopkins Medicine indicates that approximately 10 to 15% of individuals with Crohn's disease have relatives affected by the disorder. Similarly, around 5 to 7% of patients diagnosed with ulcerative colitis have a familial history of the condition.

Reimbursement strategies implemented by key industry players to mitigate healthcare costs are expected to foster favorable patient perceptions regarding effective treatment options. Increased investments in intestinal fistula treatment are also projected to yield significant returns on investment (ROI), particularly as physicians commonly prescribe these medications for managing moderate to severe intestinal fistula cases. Furthermore, the development of anti-adhesion molecules, particularly integrin antagonists, presents a promising avenue for addressing anal fistula. These molecules target the molecular mechanisms involved in adhesion formation, potentially reducing the recurrence of fistulas and improving patient outcomes.

Anal Fistula Treatment Market Report Highlights

In 2023, the surgical segment accounted for the largest market share due to interventions, particularly fistula surgery, that emerged as the recommended and preferred approach for addressing anal fistulas among patients.

The hospital segment is expected to witness the fastest CAGR during the forecast period due to specialized departments and facilities equipped with advanced medical infrastructure, including surgical units and diagnostic capabilities.

North America dominated the largest market share in 2023, due to advanced healthcare infrastructure with well-equipped hospitals, clinics, and specialized healthcare facilities. The availability of state-of-the-art diagnostic and treatment resources contributes to effective and comprehensive anal fistula management.

Asia Pacific region is expected to witness the fastest CAGR during the forecast period on account of the presence of a huge population suffering from intestinal disorders.

The global players include Avante Health, Biolitec, Cliniva Healthcare, Cook Medical, Gulmaher Surgico, KARL STORZ, Novo Surgical, and more.

Polaris Market Research has segmented the anal fistula treatment market report based on drug type, treatment type, application, end use, and region:

Anal Fistula Treatment, Durg Type Outlook (Revenue - USD Billion, 2019- 2032)

  • Anticholinergic
  • Proton-Pump Inhibitors
  • H2 Blockers
  • Antidiarrheals

Anal Fistula Treatment, Treatment Type Outlook (Revenue - USD Billion, 2019- 2032)

  • Surgical
  • Non-Surgical

Anal Fistula Treatment, Application Outlook (Revenue - USD Billion, 2019- 2032)

  • Intersphincteric Fistula
  • Transsphincteric Fistula
  • Suprasphincteric Fistula
  • Others

Anal Fistula Treatment, End Use Outlook (Revenue - USD Billion, 2019- 2032)

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Anal Fistula Treatment, Regional Outlook (Revenue - USD Billion, 2019- 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of LA
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1.Introduction

  • 1.1.Report Description
    • 1.1.1.Objectives of the Study
    • 1.1.2.Market Scope
    • 1.1.3.Assumptions
  • 1.2.Stakeholders

2.Executive Summary

  • 2.1.Market Highlights

3.Research Methodology

  • 3.1.Overview
    • 3.1.1.Data Mining
  • 3.2.Data Sources
    • 3.2.1.Primary Sources
    • 3.2.2.Secondary Sources

4.Global Anal Fistula Treatment Market Insights

  • 4.1.Anal Fistula Treatment - Industry Snapshot
  • 4.2.Anal Fistula Treatment Market Dynamics
    • 4.2.1.Drivers and Opportunities
      • 4.2.1.1.Rising incidence of bowel diseases
      • 4.2.1.2.Advancements in Treatment Technologies
    • 4.2.2.Restraints and Challenges
      • 4.2.2.1.High cost of treatment
  • 4.3.Porter's Five Forces Analysis
    • 4.3.1.Bargaining Power of Suppliers (Moderate)
    • 4.3.2.Threats of New Entrants: (Low)
    • 4.3.3.Bargaining Power of Buyers (Moderate)
    • 4.3.4.Threat of Substitute (Moderate)
    • 4.3.5.Rivalry among existing firms (High)
  • 4.4.PESTLE Analysis
  • 4.5.Anal Fistula Treatment Industry Trends
  • 4.6.Value Chain Analysis
  • 4.7.COVID-19 Impact Analysis

5.Global Anal Fistula Treatment Market, by Drug Type

  • 5.1.Key Findings
  • 5.2.Introduction
    • 5.2.1.Global Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • 5.3.Anticholinergic
    • 5.3.1.Global Anal Fistula Treatment Market, by Anticholinergic, by Region, 2019-2032 (USD Billion)
  • 5.4.Proton-Pump Inhibitors
    • 5.4.1.Global Anal Fistula Treatment Market, by Proton-Pump Inhibitors, by Region, 2019-2032 (USD Billion)
  • 5.5.H2 Blockers
    • 5.5.1.Global Anal Fistula Treatment Market, by H2 Blockers, by Region, 2019-2032 (USD Billion)
  • 5.6.Antidiarrheals
    • 5.6.1.Global Anal Fistula Treatment Market, by Antidiarrheals, by Region, 2019-2032 (USD Billion)

6.Global Anal Fistula Treatment Market, by Application

  • 6.1.Key Findings
  • 6.2.Introduction
    • 6.2.1.Global Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • 6.3.Intersphincteric Fistula
    • 6.3.1.Global Anal Fistula Treatment Market, by Intersphincteric Fistula, by Region, 2019-2032 (USD Billion)
  • 6.4.Transsphincteric Fistula
    • 6.4.1.Global Anal Fistula Treatment Market, by Transsphincteric Fistula, by Region, 2019-2032 (USD Billion)
  • 6.5.Suprasphincteric Fistula
    • 6.5.1.Global Anal Fistula Treatment Market, by Suprasphincteric Fistula, by Region, 2019-2032 (USD Billion)
  • 6.6.Others
    • 6.6.1.Global Anal Fistula Treatment Market, by Others, by Region, 2019-2032 (USD Billion)

7.Global Anal Fistula Treatment Market, by End-use

  • 7.1.Key Findings
  • 7.2.Introduction
    • 7.2.1.Global Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 7.3.Hospitals
    • 7.3.1.Global Anal Fistula Treatment Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 7.4.Ambulatory Surgical Centers
    • 7.4.1.Global Anal Fistula Treatment Market, by Ambulatory Surgical Centers, by Region, 2019-2032 (USD Billion)
  • 7.5.Others
    • 7.5.1.Global Anal Fistula Treatment Market, by Others, by Region, 2019-2032 (USD Billion)

8.Global Anal Fistula Treatment Market, by Treatment Type

  • 8.1.Key Findings
  • 8.2.Introduction
    • 8.2.1.Global Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • 8.3.Surgical
    • 8.3.1.Global Anal Fistula Treatment Market, by Surgical, by Region, 2019-2032 (USD Billion)
  • 8.4.Non-Surgical
    • 8.4.1.Global Anal Fistula Treatment Market, by Non-Surgical, by Region, 2019-2032 (USD Billion)

9.Global Anal Fistula Treatment Market, by Geography

  • 9.1.Key findings
  • 9.2.Introduction
    • 9.2.1.Anal Fistula Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3.Anal Fistula Treatment Market - North America
    • 9.3.1.North America: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.3.2.North America: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.3.3.North America: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.3.4.North America: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.3.5.Anal Fistula Treatment Market - U.S.
      • 9.3.5.1.U.S.: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.3.5.2.U.S.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.3.5.3.U.S.: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.3.5.4.U.S.: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.3.6.Anal Fistula Treatment Market - Canada
      • 9.3.6.1.Canada: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.3.6.2.Canada: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.3.6.3.Canada: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.3.6.4.Canada: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 9.4.Anal Fistula Treatment Market - Europe
    • 9.4.1.Europe: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.4.2.Europe: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.4.3.Europe: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.4.4.Europe: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.5.Anal Fistula Treatment Market - UK
      • 9.4.5.1.UK: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.5.2.UK: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.5.3.UK: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.5.4.UK: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.6.Anal Fistula Treatment Market - France
      • 9.4.6.1.France: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.6.2.France: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.6.3.France: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.6.4.France: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.7.Anal Fistula Treatment Market - Germany
      • 9.4.7.1.Germany: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.7.2.Germany: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.7.3.Germany: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.7.4.Germany: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.8.Anal Fistula Treatment Market - Italy
      • 9.4.8.1.Italy: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.8.2.Italy: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.8.3.Italy: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.8.4.Italy: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.9.Anal Fistula Treatment Market - Spain
      • 9.4.9.1.Spain: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.9.2.Spain: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.9.3.Spain: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.9.4.Spain: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.10.Anal Fistula Treatment Market - Netherlands
      • 9.4.10.1.Netherlands: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.10.2.Netherlands: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.10.3.Netherlands: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.10.4.Netherlands: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.11.Anal Fistula Treatment Market - Russia
      • 9.4.11.1.Russia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.11.2.Russia.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.11.3.Russia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.11.4.Russia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 9.5.Anal Fistula Treatment Market - Asia Pacific
    • 9.5.1.Asia Pacific: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.5.2.Asia Pacific: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.5.3.Asia Pacific: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.5.4.Asia Pacific: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.5.Anal Fistula Treatment Market - China
      • 9.5.5.1.China: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.5.2.China.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.5.3.China: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.5.4.China: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.6.Anal Fistula Treatment Market - India
      • 9.5.6.1.India: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.6.2.India.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.6.3.India: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.6.4.India: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.7.Anal Fistula Treatment Market - Japan
      • 9.5.7.1.Japan: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.7.2.Japan.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.7.3.Japan: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.7.4.Japan: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.8.Anal Fistula Treatment Market - Malaysia
      • 9.5.8.1.Malaysia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.8.2.Malaysia.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.8.3.Malaysia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.8.4.Malaysia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.9.Anal Fistula Treatment Market - Indonesia
      • 9.5.9.1.Indonesia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.9.2.Indonesia.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.9.3.Indonesia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.9.4.Indonesia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.10.Anal Fistula Treatment Market - South Korea
      • 9.5.10.1.South Korea: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.10.2.South Korea.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.10.3.South Korea: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.10.4.South Korea: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 9.6.Anal Fistula Treatment Market - Middle East & Africa
    • 9.6.1.Middle East & Africa: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.6.2.Middle East & Africa: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.6.3.Middle East & Africa: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.6.4.Middle East & Africa: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.6.5.Anal Fistula Treatment Market - Saudi Arabia
      • 9.6.5.1.Saudi Arabia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.5.2.Saudi Arabia: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.6.5.3.Saudi Arabia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.6.5.4.Saudi Arabia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.6.6.Anal Fistula Treatment Market - South Africa
      • 9.6.6.1.South Africa: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.6.2.South Africa: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.6.6.3.South Africa: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.6.6.4.South Africa: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.6.7.Anal Fistula Treatment Market - Israel
      • 9.6.7.1.Israel: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.7.2.Israel: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.6.7.3.Israel: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.6.7.4.Israel: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.6.8.Anal Fistula Treatment Market - UAE
      • 9.6.8.1.UAE: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.8.2.UAE: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.6.8.3.UAE: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.6.8.4.UAE: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 9.7.Anal Fistula Treatment Market - Latin America
    • 9.7.1.Latin America: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.7.2.Latin America: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.7.3.Latin America: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.7.4.Latin America: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.7.5.Anal Fistula Treatment Market - Mexico
      • 9.7.5.1.Mexico: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.7.5.2.Mexico: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.7.5.3.Mexico: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.7.5.4.Mexico: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.7.6.Anal Fistula Treatment Market - Brazil
      • 9.7.6.1.Brazil: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.7.6.2.Brazil: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.7.6.3.Brazil: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.7.6.4.Brazil: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.7.7.Anal Fistula Treatment Market - Argentina
      • 9.7.7.1.Argentina: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.7.7.2.Argentina: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.7.7.3.Argentina: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.7.7.4.Argentina: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)

10.Competitive Landscape

  • 10.1.Expansion and Acquisition Analysis
    • 10.1.1.Expansion
    • 10.1.2.Acquisitions
  • 10.2.Partnerships/Collaborations/Agreements/Exhibitions

11.Company Profiles

  • 11.1.Angiplast Pvt. Ltd.
    • 11.1.1.Company Overview
    • 11.1.2.Financial Performance
    • 11.1.3.Product Benchmarking
    • 11.1.4.Recent Development
  • 11.2.Avante Health Solutions
    • 11.2.1.Company Overview
    • 11.2.2.Financial Performance
    • 11.2.3.Product Benchmarking
    • 11.2.4.Recent Development
  • 11.3.Biolitec AG
    • 11.3.1.Company Overview
    • 11.3.2.Financial Performance
    • 11.3.3.Product Benchmarking
    • 11.3.4.Recent Development
  • 11.4.Cliniva Healthcare
    • 11.4.1.Company Overview
    • 11.4.2.Financial Performance
    • 11.4.3.Product Benchmarking
    • 11.4.4.Recent Development
  • 11.5.Cook Medical
    • 11.5.1.Company Overview
    • 11.5.2.Financial Performance
    • 11.5.3.Product Benchmarking
    • 11.5.4.Recent Development
  • 11.6.Gulmaher Surgico
    • 11.6.1.Company Overview
    • 11.6.2.Financial Performance
    • 11.6.3.Product Benchmarking
    • 11.6.4.Recent Development
  • 11.7.Integra LifeSciences
    • 11.7.1.Company Overview
    • 11.7.2.Financial Performance
    • 11.7.3.Product Benchmarking
    • 11.7.4.Recent Development
  • 11.8.KARL STORZ
    • 11.8.1.Company Overview
    • 11.8.2.Financial Performance
    • 11.8.3.Product Benchmarking
    • 11.8.4.Recent Development
  • 11.9.Medtronic plc
    • 11.9.1.Company Overview
    • 11.9.2.Financial Performance
    • 11.9.3.Product Benchmarking
    • 11.9.4.Recent Development
  • 11.10.Novo Surgical Inc.
    • 11.10.1.Company Overview
    • 11.10.2.Financial Performance
    • 11.10.3.Product Benchmarking
    • 11.10.4.Recent Development
  • 11.11.Signum Surgical
    • 11.11.1.Company Overview
    • 11.11.2.Financial Performance
    • 11.11.3.Product Benchmarking
    • 11.11.4.Recent Development
  • 11.12.Sklar Surgical Instruments
    • 11.12.1.Company Overview
    • 11.12.2.Financial Performance
    • 11.12.3.Product Benchmarking
    • 11.12.4.Recent Development

List of Tables

  • Table 1 Global Anal Fistula Treatment Market, by Drug Type, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Anal Fistula Treatment Market, by Application, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Anal Fistula Treatment Market, by End-use, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Anal Fistula Treatment Market, by Treatment Type, by Region, 2019-2032 (USD Billion)
  • Table 5 Anal Fistula Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 7 North America: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 8 North America: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 9 North America: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 11 U.S.: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 12 U.S.: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 13 U.S.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 14 Canada: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 15 Canada: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Canada: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 17 Canada: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 18 Europe: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 19 Europe: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 20 Europe: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 21 Europe: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 22 Germany: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 23 Germany: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 24 Germany: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 25 Germany: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 26 France: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 27 France: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 28 France: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 29 France: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 30 UK: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 31 UK: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 32 UK: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 33 UK: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 34 Italy: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 35 Italy: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 36 Italy: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 37 Italy: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 42 Spain: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 43 Spain: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 44 Spain: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 45 Spain: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 46 Russia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 47 Russia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 48 Russia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 49 Russia: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 54 China: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 55 China: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 56 China: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 57 China: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 58 Japan: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 59 Japan: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 60 Japan: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 61 Japan: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 62 India: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 63 India: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 64 India: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 65 India: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 74 South Korea: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 75 South Korea: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 76 South Korea: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 77 South Korea: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 78 Latin America: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 79 Latin America: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 80 Latin America: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 81 Latin America: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 83 Brazil: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 84 Brazil: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 85 Brazil: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 86 Mexico: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 87 Mexico: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 88 Mexico: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 89 Mexico: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 90 Argentina: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 91 Argentina: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 92 Argentina: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 93 Argentina: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 98 UAE: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 99 UAE: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 100 UAE: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 101 UAE: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 106 South Africa: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 107 South Africa: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 108 South Africa: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 109 South Africa: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 110 Israel: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 111 Israel: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 112 Israel: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 113 Israel: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Anal Fistula Treatment Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Treatment Type
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Drug Type
  • Figure 7. Global Anal Fistula Treatment Market, by Drug Type, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Treatment Type
  • Figure 9. Global Anal Fistula Treatment Market, by Treatment Type, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Anal Fistula Treatment Market, by Application, 2021 & 2030 (USD Billion)
  • Figure 12. Market by End-use
  • Figure 13. Global Anal Fistula Treatment Market, by End-use, 2021 & 2030 (USD Billion)